118 related articles for article (PubMed ID: 7804695)
1. Secondary malignancies after marrow transplantation for leukemia or aplastic anemia.
Witherspoon RP; Deeg HJ; Storb R
Transplant Sci; 1994 Sep; 4(1):33-41. PubMed ID: 7804695
[TBL] [Abstract][Full Text] [Related]
2. [Post-transplant EBV-associated lymphoproliferative disorders--report of two cases].
Iwami H; Misawa A; Tsunamoto K; Kasubuchi Y; Naya M; Hojo M; Goto T; Hibi S; Matsumura T; Todo S; Imashuku S
Rinsho Ketsueki; 1998 Mar; 39(3):198-204. PubMed ID: 9577643
[TBL] [Abstract][Full Text] [Related]
3. Secondary malignancies after marrow transplantation for leukemia or aplastic anemia.
Witherspoon RP; Deeg HJ; Storb R
Transplantation; 1994 May; 57(10):1413-8. PubMed ID: 8197599
[No Abstract] [Full Text] [Related]
4. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
[TBL] [Abstract][Full Text] [Related]
5. Malignant diseases after allogeneic bone marrow transplantation: an updated overview.
Socié G; Henry-Amar M; Devergie A; Esperou-Bourdeau H; Ribaud P; Traineau R; Gluckman E
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S75-7. PubMed ID: 8177721
[TBL] [Abstract][Full Text] [Related]
6. Duration of Epstein-Barr virus (EBV)-associated polyclonal lymphoproliferative disease (LPD) following bone marrow transplantation.
Imashuku S; Iwami H; Tsunamoto K; Hibi S; Todo S
Bone Marrow Transplant; 1996 Oct; 18(4):823-4. PubMed ID: 8899207
[No Abstract] [Full Text] [Related]
7. Relationship of immunodeficiency to lymphoid malignancy.
Kersey JH; Shapiro RS; Filipovich AH
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S10-2. PubMed ID: 2840629
[TBL] [Abstract][Full Text] [Related]
8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
9. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytosis of donor origin in cerebrospinal fluid, and marrow aplasia after donor leukocyte infusion for EBV-lymphoproliferative disease.
Gharpure V; Rubin L; Amlin J; Emanuel D; Schroeder W; Davidson A; Hromas R; Cornetta K
Bone Marrow Transplant; 1996 Jul; 18(1):221-4. PubMed ID: 8832021
[TBL] [Abstract][Full Text] [Related]
11. [Indications, technique and risks in bone marrow transplantation in adulthood].
Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W
Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901
[TBL] [Abstract][Full Text] [Related]
12. T cell lymphoproliferative disorder following bone marrow transplantation for severe aplastic anemia.
Wang LC; Lu MY; Yu J; Jou ST; Chiang IP; Lin KH; Lin DT
Bone Marrow Transplant; 2000 Oct; 26(8):893-7. PubMed ID: 11081391
[TBL] [Abstract][Full Text] [Related]
13. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
Yago K; Itoh M; Shimada H
Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
[TBL] [Abstract][Full Text] [Related]
14. Alpha-interferon therapy for lymphoproliferative disorders developing in two children following bone marrow transplants.
Trigg ME; de Alarcon P; Rumelhart S; Holida M; Giller R
J Biol Response Mod; 1989 Dec; 8(6):603-13. PubMed ID: 2480993
[TBL] [Abstract][Full Text] [Related]
15. Prolonged remission of Epstein-Barr virus associated lymphoma secondary to T cell-depleted bone marrow transplantation.
Lyttelton MP; Browett PJ; Brenner MK; Norton JD; Kolman JL; McGee JO; Hamilton-Dutoit S; Hoffbrand AV; Prentice HG
Bone Marrow Transplant; 1988 Nov; 3(6):641-6. PubMed ID: 2850832
[TBL] [Abstract][Full Text] [Related]
16. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
17. Secondary malignancies after bone marrow transplantation in adults.
Lowsky R; Lipton J; Fyles G; Minden M; Meharchand J; Tejpar I; Atkins H; Sutcliffe S; Messner H
J Clin Oncol; 1994 Oct; 12(10):2187-92. PubMed ID: 7931488
[TBL] [Abstract][Full Text] [Related]
18. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
19. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
[TBL] [Abstract][Full Text] [Related]
20. Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.
O'Reilly RJ; Lacerda JF; Lucas KG; Rosenfield NS; Small TN; Papadopoulos EB
Important Adv Oncol; 1996; ():149-66. PubMed ID: 8791134
[No Abstract] [Full Text] [Related]
[Next] [New Search]
